Advanced Clinical Practitioner-led Palliative Care Heart Failure Model within the National Health Service: A Prospective Study of Patient Experience, Healthcare Costs and End-of-life Outcomes

Aim Despite growing evidence of palliative care (PC) benefits in heart failure (HF), its integration into standard practice remains limited across the UK. Patients with advanced HF often experience poor quality of life (QoL), recurrent hospitalisations, and fragmented care. This study evaluated the impact of a guideline-informed, Heart Failure Advanced Clinical Practitioner (HFACP)-led palliative HF model incorporating telehealth on QoL, healthcare utilisation, costs, and end-of-life outcomes. Methods and Results This prospective mixed-methods cohort study (March 2023–March 2025) followed 100 patients with advanced HF receiving home-based PC interventions over 6-months. Primary outcomes included QoL (KCCQ-23 and EQ-5D-5L), healthcare cost savings, advance care planning (ACP) uptake and preferred place of death. Patient satisfaction was assessed at three months. Among 100 patients (mean age 76±13 60% male), 81 completed ACP discussions. Of 54 eligible patients for telehealth, only 29% participated. Mean EQ-5D-5L scores declined from baseline to six months (0.38 to 0.30), while KCCQ-23 scores decreased from 37.8 to 33.3. Despite this, 93% rated their care positively. KCCQ summary scores <45 were associated with increased one-year mortality, HF admissions and healthcare use. Of 26 deaths, 11 (42.3%) occurred at home, aligning with patient preferences. Hospital avoidance interventions generated estimated savings of £672,743.50 over the two-year study period. Conclusion The HFACP-led model achieved high patient satisfaction, increased ACP engagement, and substantial cost savings. However, declining QOL scores and limited telehealth suggest opportunities for targeted strategies including earlier referral to PC services. Low KCCQ may identify patients with limited survival requiring timely palliative interventions.